-
150-Year-Old Aetna Pitches Itself As A Growth Company
Monday, May 15, 2017 - 8:30am | 414Read More...Few investors consider a 150-year-old company as one that has a pathway toward growth, but there are always exceptions to every rule. Barclays' Joshua Raskin maintains an Overweight rating on the 150-year old diversified healthcare company Aetna Inc (NYSE: AET) with a $162 price target. In a...
-
Healthways Upgraded By Barclays On Improved Operating Focus
Monday, August 22, 2016 - 10:29am | 347Read More...Barclays upgraded the shares of Healthways, Inc. (NASDAQ: HWAY) from an Underweight to an Equal-Weight rating. The brokerage also boosted the price target from $12 to $27, citing enhanced returns due to transformation. Analyst Joshua Raskin pointed out that the company maintained a portfolio of...
-
HealthSouth Risk/Reward Profile Grows Worse
Monday, June 27, 2016 - 10:29am | 222Read More...Barclays' Joshua Raskin has downgraded HealthSouth Corp (NYSE: HLS) to Underweight from Equal Weight on unfavorable risk/reward. Following are Raskin's seven reasons for the downgrade: "We believe there is increasing scrutiny around IRF payments in the Medicare program, including updated MedPAC...
-
Barclays Analyst Sees Sick Shifting From Hospitals To Outpatient Clinics
Thursday, January 8, 2015 - 4:30pm | 235Read More...A shift to outpatient facilities from hospitals will continue to accelerate under healthcare reform and favor companies well-positioned for the switch, an analyst said Thursday. "We're seeing a clear movement to outpatient services," Barclay's Joshua Raskin said, calling 2014...
